The original patent documentation describes this mechanism in detail, noting that the peptide stimulates lipolysis and inhibits lipogenesis via beta-adrenergic signalling at concentrations far below those needed to activate growth-promoting pathways
Besides people in whom CJC-1295 and ipamorelin may pose an elevated health risk, the treatments are broadly contraindicated in: People who are pregnant or breastfeeding, as there isnt enough evidence to determine their general safety for the developing fetus or newborn People who fear needles, as subcutaneous injection is the most common route of administration Competitive weight lifters or bodybuilders less for safety reasons than because these peptides are prohibited by the World Anti-Doping Agency Where to find CJC-1295 and ipamorelin The only way to get medical-grade CJC-1295 and ipamorelin is from an accredited compounding pharmacy, after visiting with a licensed clinician
This window is where the most dramatic changes typically occur
It is primarily used to treat type 2 diabetes, but it has also shown potential for weight management
It is not approved as a drug, food, cosmetic, or medical product and is not intended for human or animal use
Bacteroides dorei dominates gut microbiome prior to autoimnnunity in Finnish children at high risk for type 1 diabetes
